Dasynoc
FDA concerns delay Xspray Pharma's Dasynoc approval again
Xspray Pharma announces that the FDA's decision on market approval for Dasynoc is again delayed due to GMP complaints at an external...
Bioteknik
Premium
BioStock Investor Pitch: Market next for Xspray Pharma
Xspray Pharma is in the final stages of preparations for...
Intervju
Video
Capital injection to bring Xspray to market
Xspray Pharma is in the final stages of preparations...
Xspray wants to launch better cancer drugs – CEO explains how
Xspray Pharma develops improved versions of already established...
Intervju
Video
Xspray's CEO on the 2025 launch plan
Preparations are underway, market partner established and FDA application...
Intervju